A study to investigate lung deposition of radiolabelled OligoG (v1.0)

• Research type

  Research Study

• Full title

  An open label, randomised, two-way crossover scintigraphic study to investigate lung deposition of radiolabelled OligoG delivered as a dry powder and as a nebulised solution in cystic fibrosis patients

• IRAS ID

  142749

• Contact name

  Howard Stevens

• Contact email

  howard.stevens@bio-imagesgroup.com

• Sponsor organisation

  AlgiPharma AS

• Eudract number

  2013-003774-27

• REC name

  Scotland A REC

• REC reference

  13/SS/0212

• Date of REC Opinion

  12 Dec 2013

• REC opinion

  Further Information Favourable Opinion